57 completed, 19 unknown, 11 terminated, 4 not yet recruiting. 100 Phase 2, 16 Phase 3, 14 Phase 1.
Follow Folic Acid: new trials by email Literature Review of Folic Acid trials Research Report on Folic Acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Furosemide vs Placebo in Severe Preeclampsia Postpartum Furosemide, Folic Acid 5 MG - Severe Preeclampsia | Phase 2 | Not yet recruiting | Universidad Nacional Autonoma de Honduras | 186 | 2026-11-02 | 2026-11-05 |
| Safety and Efficacy of Folic Acid Combined With Atezolizumab and Bevacizumab as First-Line Therapy for Unresectable Hepatocellular Carcinoma Folic Acid, Atezolizumab & Bevacizumab - Unresectable Hepatocellular Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | West China Hospital | 78 | 2026-10-01 | 2026-09-23 |
| Prospective Management of Plaque Instability With Statins and Extra Folic Acid Atorvastatin plus folic acid, Atorvastatin - Carotid Atherosclerotic Plaque | Phase 1 / Phase 2 | Recruiting | Ruijin Hospital | 180 | 2026-03-01 | 2026-07-02 |
| Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization Somatropin (4IU for 1 month) plus, folic acid 400 mcg per day., DHEA plus folic acid 400mcg per day, control group - Infertility, Infertility (IVF Patients) | Phase 2 / Phase 3 | Recruiting | Beni-Suef University | 165 | 2025-10-10 | 2026-01-07 |
| Baricitinib in CPPD - the BAPTIST Study Baricitinib 4 MG Oral Tablet, Methylprednisolone (Corticosteroid), Colchicine 1 MG Oral Tablet - Calcium Pyrophosphate Deposition Disease, Chondrocalcinosis | Phase 2 | Not yet recruiting | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | 32 | 2025-01-01 | 2025-01-10 |
| Folic Acid Supplementation in Calcific Aortic Valve Disease Folic Acid Oral Tablet, Placebo - Calcification of Aortic Valve, Aortic Valve Stenosis | Phase 2 | Not yet recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 100 | 2023-07-01 | 2023-05-17 |
| Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients Pembrolizumab, Bevacizumab, Pemetrexed - Non-squamous NSCLC | Phase 2 | Active not recruiting | Shanghai Chest Hospital | 54 | 2023-06-27 | 2026-03-11 |
| Effect of Folic Acid in Levodopa Treated Parkinson's Disease Patients Folic Acid Tablet, Placebo - Parkinson Disease | Phase 2 | Unknown | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 60 | 2023-04-16 | 2023-09-26 |
| Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases Oxaliplatin, S1, Cetuximab - For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method | Phase 2 | Unknown | Liaoning Cancer Hospital & Institute | 100 | 2023-03-15 | 2023-03-20 |
| Early Blocking Strategy for Metachronous Liver Metastasis of Colorectal Cancer Based on Pre-hepatic CTC Detection Oxaliplatin, S1, Cetuximab - Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer | Phase 2 | Unknown | Liaoning Cancer Hospital & Institute | 100 | 2023-03-01 | 2023-02-09 |
| Comparison of Acetyl- L- Carnitine& Folic Acid Versus Coenzyme Q10& Folic Acid on Semen& Hormonal Parameters& Semen Oxidative Status in Patients of Primary Infertility. A Double Blind Randomized Clinical Trial Acetyl-l-carnitine, folic acid - Infertility | Phase 2 | Completed | Khyber Medical University Peshawar | 86 | 2022-08-06 | 2022-11-30 |
| Natrunix Versus Methotrexate in Rheumatoid Arthritis Natrunix with MTX placebo (+folate), Natrunix placebo with MTX (+folate) - Rheumatoid Arthritis | Phase 2 | Unknown | XBiotech, Inc. | 150 | 2022-06-15 | 2022-05-06 |
| Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) Cobalamin, Dexamethasone, Docetaxel - Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma | Phase 2 / Phase 3 | Active not recruiting | SWOG Cancer Research Network | 82 | 2022-03-15 | 2026-05-18 |
| Intrathecal Pemetrexed for Leptomeningeal Metastasis Pemetrexed (1), Pemetrexed (2), Folic Acid - Leptomeningeal Metastases | Phase 1 / Phase 2 | Completed | The First Hospital of Jilin University | 34 | 2022-02-21 | 2025-05-04 |
| Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss Prednisone, Progesterone, vit D - Recurrent Pregnancy Loss(RPL), Recurrent Miscarriage | Phase 2 / Phase 3 | Unknown | Soroka University Medical Center | 242 | 2020-12-01 | 2020-09-22 |
| KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC Telaglenastat, Carboplatin Chemotherapy, Pemetrexed Chemotherapy - Non-Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer | Phase 2 | Terminated | Calithera Biosciences, Inc | 40 | 2020-07-24 | 2022-09-21 |
| Treatment for COVID-19 in High-Risk Adult Outpatients Ascorbic Acid, Hydroxychloroquine Sulfate, Azithromycin - COVID-19, SARS-CoV-2 | Phase 2 / Phase 3 | Terminated | University of Washington | 289 | 2020-04-16 | 2022-08-08 |
| Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG Nivolumab, relatlimab, Oxaliplatin - Gastric Cancer, Adenocarcinoma of the Esophagogastric Junction | Phase 2 | Unknown | University Hospital, Essen | 21 | 2019-09-26 | 2024-03-12 |
| Jianpi Huoxue Recipe in Treating Gastric Premalignant Lesion MoLuoDan, Sanchi powder, Folic Acid Tablet - Gastric Precancerous Condition | Phase 1 / Phase 2 | Unknown | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 480 | 2019-03-01 | 2021-06-25 |
| Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia Levocarnitine, Vitamin B Complex - Acute Lymphoblastic Leukemia, Hyperbilirubinemia | Phase 2 | Terminated | M.D. Anderson Cancer Center | 10 | 2018-05-17 | 2025-09-05 |
Showing 20 of 100. Sign in to see all of them.
Arthritis, Rheumatoid (15) · Carcinoma, Non-Small-Cell Lung (9) · Colorectal Neoplasms (6) · Lung Neoplasms (6) · Infertility (5) · Recurrence (4) · Arthritis (3) · Breast Neoplasms (3) · Hypertension (3) · Lymphoma, T-Cell, Peripheral (3) · Neoplasm Metastasis (3) · Polycystic Ovary Syndrome (3) · Abortion, Habitual (2) · Adenoma (2) · Anemia (2)
Acrotech Biopharma Inc. (4) · Eli Lilly and Company (3) · Lagos State University (3) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (2) · Emory University (2) · Genentech, Inc. (2) · GlaxoSmithKline (2) · Liaoning Cancer Hospital & Institute (2) · Spectrum Pharmaceuticals, Inc (2) · University of Alabama at Birmingham (2) · 4SC AG (1) · AIO-Studien-gGmbH (1) · Ain Shams Maternity Hospital (1) · Ain Shams University (1) · All India Institute of Medical Sciences, Bhubaneswar (1)
United States (34) · China (10) · Germany (8) · United Kingdom (8) · Czechia (7) · Spain (7) · Italy (6) · Poland (6) · Australia (5) · Brazil (5) · Canada (5) · India (5) · Mexico (5) · Argentina (4) · Belgium (4)
A O Dosunmu, M.D. (2) · Garry Weems, PharmD (2) · Adetokunbo O Tayo, M.D. (1) · Ahmed Mamdouh (1) · Aiping Shi, Doctor (1) · Alan Ho, MD, PhD (1) · Alex Palatnik, MD (1) · Aline G. Ferrari, MD (1) · Arthur A Kavanaugh, MD (1) · Arun Rajan, M.D. (1)
PMID 11877368, PMID 12621133, PMID 14561807, PMID 15476202, PMID 16208639, PMID 17118406, PMID 17551129, PMID 19118243, PMID 19201496, PMID 19605506, PMID 19729414, PMID 19901100, PMID 19923375, PMID 20413687, PMID 20592433, PMID 20805005, PMID 21067804, PMID 21270268, PMID 21360491, PMID 21703683, PMID 21853931, PMID 22150039, PMID 22170358, PMID 22209480, PMID 22328739, PMID 22606998, PMID 22740496, PMID 22748101, PMID 22877941, PMID 22885417, PMID 23075681, PMID 23357459, PMID 23431372, PMID 23518033, PMID 23616513, PMID 23726971, PMID 23900207, PMID 23902779, PMID 24097378, PMID 24297381, PMID 24699939, PMID 24812310, PMID 25103444, PMID 25175924, PMID 25733246, PMID 25771069, PMID 25802345, PMID 26098427, PMID 26630680, PMID 26962106
2008 (2), 2009 (2), 2014 (2), 2015 (1), 2016 (1), K23HL098744 (1), P30AG028740 (1), P60AR047782 (1), R01AG017160 (1), R01HL135183 (1), R29AR042674 (1), U10CA180888 (1)